86 related articles for article (PubMed ID: 2068931)
1. The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological study.
Cortesina G; De Stefani A; Galeazzi E; Bussi M; Giordano C; Cavallo GP; Jemma C; Vai S; Forni G; Valente G
Acta Otolaryngol; 1991; 111(2):428-33. PubMed ID: 2068931
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
[TBL] [Abstract][Full Text] [Related]
3. Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.
Valente G; De Stefani A; Jemma C; Giovarelli M; Geuna M; Cortesina G; Forni G; Palestro G
Mod Pathol; 1990 Nov; 3(6):702-8. PubMed ID: 2263594
[TBL] [Abstract][Full Text] [Related]
4. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
[TBL] [Abstract][Full Text] [Related]
5. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
[TBL] [Abstract][Full Text] [Related]
6. [The effect of IL-2 injection around the metastatic cervical lymphnode].
Ogasawara H; Takeda N; Takeda N; Kumoi T
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1119-22. PubMed ID: 2398297
[TBL] [Abstract][Full Text] [Related]
7. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity.
Murali PS; Somasundaram R; Rao RS; Fakih AR; Gangal SG
J Oral Pathol Med; 1989 Jul; 18(6):327-32. PubMed ID: 2810131
[TBL] [Abstract][Full Text] [Related]
9. Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinoma.
Musiani P; De Campora E; Valitutti S; Castellino F; Calearo C; Cortesina G; Giovarelli M; Jemma C; De Stefani A; Forni G
J Biol Response Mod; 1989 Dec; 8(6):571-8. PubMed ID: 2600601
[TBL] [Abstract][Full Text] [Related]
10. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
Ohta T; Kikuchi H; Ogata H; Iwata K; Yoshida K; Katayama K; Watanabe H
Cancer; 1992 Aug; 70(4):741-8. PubMed ID: 1386555
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
12. Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations.
De Stefani A; Valente G; Forni G; Lerda W; Ragona R; Cortesina G
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):125-33. PubMed ID: 8732695
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with autologous tumor-infiltrating lymphocytes and recombinant interleukin-2 in patients with lung carcinoma].
Li D; Zhang X; Song Y
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):152-5. PubMed ID: 7656811
[TBL] [Abstract][Full Text] [Related]
14. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
Wang MB; Lichtenstein A; Mickel RA
Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer.
Cortesina G; De Stefani A; Galeazzi E; Cavallo GP; Jemma C; Giovarelli M; Vai S; Forni G
Head Neck; 1991; 13(2):125-31. PubMed ID: 2022477
[TBL] [Abstract][Full Text] [Related]
16. Combined-modality treatment with induction chemotherapy in locally advanced squamous cell carcinoma of the oral cavity and oropharynx.
Abele R; Lehmann W; Pipard G; Alberto P
Recent Results Cancer Res; 1985; 98():142-7. PubMed ID: 4035070
[No Abstract] [Full Text] [Related]
17. Perilymphatic injections of recombinant interleukin-2 (rIL-2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma.
Melioli G; Margarino G; Scala M; Mereu P; Bertoglio S; Schenone G; Barbaresi M; Machà AM; Santi L; Badellino F
Laryngoscope; 1992 May; 102(5):572-8. PubMed ID: 1533435
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx.
De Stefani A; Forni G; Ragona R; Cavallo G; Bussi M; Usai A; Badellino F; Cortesina G
Cancer; 2002 Jul; 95(1):90-7. PubMed ID: 12115321
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
